Search research articles
Contact Us
Filters
Showing results (71-80 of 95) with videos related to
Page
of 10
Sort By:
Maturitas
|
September 24, 2024
Ultra-low dose estradiol and dydrogesterone for the treatment of menopausal symptoms in a pooled, multi-ethnic population
John C Stevenson, Mulan Ren, Elke Kahler, et al.
Climacteric : the Journal of the International Menopause Society
|
July 30, 2024
Ultra-low-dose estradiol and dydrogesterone for treatment of vasomotor symptoms in Europe and China
Qi Yu, John C Stevenson, Tetiana Tatarchuk, et al.
Maturitas
|
April 8, 2020
Early menopause is associated with increased risk of arterial hypertension: A systematic review and meta-analysis
Panagiotis Anagnostis, Patroklos Theocharis, Konstantinos Lallas, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
July 8, 2024
Ultra-low-dose continuous combined estradiol and dydrogesterone in postmenopausal women: A pooled safety and tolerability analysis
Tetiana Tatarchuk, John C Stevenson, Qi Yu, et al.
Climacteric : the Journal of the International Menopause Society
|
October 30, 2024
Low-dose and ultra-low-dose estradiol and dydrogesterone in postmenopause: an analysis by body mass index
Mulan Ren, Qi Yu, Marcelo Graziano Custodio, et al.
Climacteric : the Journal of the International Menopause Society
|
August 7, 2025
Major adverse cardiovascular events risk in menopausal women treated with oral estradiol/micronized progesterone versus conjugated estrogens/medroxyprogesterone: a claims data analysis in the USA
John C Stevenson, Rodney Baber, Risa Kagan, et al.
Maturitas
|
April 9, 2017
Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement
Faustino R Pérez-López, Iuliana Ceausu, Herman Depypere, et al.
Maturitas
|
May 11, 2005
Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy
Sven O Skouby, Farook Al-Azzawi, David Barlow, et al.
Maturitas
|
September 14, 2016
A model of care for healthy menopause and ageing: EMAS position statement
Petra Stute, Iuliana Ceausu, Herman Depypere, et al.
Maturitas
|
November 25, 2017
Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide
Antonio Cano, Peter Chedraui, Dimitrios G Goulis, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 95) with videos related to
Sort By:
Page
of 10
Maturitas
|
September 24, 2024
Ultra-low dose estradiol and dydrogesterone for the treatment of menopausal symptoms in a pooled, multi-ethnic population
John C Stevenson, Mulan Ren, Elke Kahler, et al.
Climacteric : the Journal of the International Menopause Society
|
July 30, 2024
Ultra-low-dose estradiol and dydrogesterone for treatment of vasomotor symptoms in Europe and China
Qi Yu, John C Stevenson, Tetiana Tatarchuk, et al.
Maturitas
|
April 8, 2020
Early menopause is associated with increased risk of arterial hypertension: A systematic review and meta-analysis
Panagiotis Anagnostis, Patroklos Theocharis, Konstantinos Lallas, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
July 8, 2024
Ultra-low-dose continuous combined estradiol and dydrogesterone in postmenopausal women: A pooled safety and tolerability analysis
Tetiana Tatarchuk, John C Stevenson, Qi Yu, et al.
Climacteric : the Journal of the International Menopause Society
|
October 30, 2024
Low-dose and ultra-low-dose estradiol and dydrogesterone in postmenopause: an analysis by body mass index
Mulan Ren, Qi Yu, Marcelo Graziano Custodio, et al.
Climacteric : the Journal of the International Menopause Society
|
August 7, 2025
Major adverse cardiovascular events risk in menopausal women treated with oral estradiol/micronized progesterone versus conjugated estrogens/medroxyprogesterone: a claims data analysis in the USA
John C Stevenson, Rodney Baber, Risa Kagan, et al.
Maturitas
|
April 9, 2017
Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement
Faustino R Pérez-López, Iuliana Ceausu, Herman Depypere, et al.
Maturitas
|
May 11, 2005
Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy
Sven O Skouby, Farook Al-Azzawi, David Barlow, et al.
Maturitas
|
September 14, 2016
A model of care for healthy menopause and ageing: EMAS position statement
Petra Stute, Iuliana Ceausu, Herman Depypere, et al.
Maturitas
|
November 25, 2017
Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide
Antonio Cano, Peter Chedraui, Dimitrios G Goulis, et al.
Page
of 10